You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
安旭生物(688075.SH):擬投建體外診斷試劑以及診斷儀器研發生產項目
格隆匯 01-12 18:16

格隆匯1月12日丨安旭生物(688075.SH)公佈,隨着新冠疫情的爆發,全球各個國家對於即時檢測的試劑以及檢測儀器的需求大大增加,尤其是國外市場需求量巨大。

為抓住行業發展機遇,滿足不斷增長的市場需求,公司擬投資建設體外診斷試劑以及診斷儀器研發生產項目,由全資子公司浙江旭民生物技術有限公司(“旭民生物”)實施,預計總投資金額50786.26萬元(最終項目投資總額以實際投資為準)。公司超募資金總額59686.04萬元,擬使用部分超募資金投入該項目。該項目是在已完成基本建設投入正常生產的年產3億件第二、第三類醫療器械、體外診斷試劑、儀器和配套產品建設項目基礎之上,繼續擴大產能。

項目建成後,將進一步擴大公司的生產規模,提升產線的自動化水平,滿足不斷增長的市場需求,同時對優化公司產品結構、擴大市場佔有率、提高品牌知名度、增強公司的綜合競爭力均具有重要意義。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account